Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026, Mar 2026, Apr 2026 and Sep 2026.
- Largest single sale: $6.5M (46,034 shares) of Protagonist Therapeutics, Inc on Sep 30, 2026. Filing
- Last sale before this period: Apr 22, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | Apr 19, 2022 | Oct 2, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 30, 2026, Protagonist Therapeutics, Inc: sold 58,629 shares for $8.3M, under a disclosed plan; 58,629 shares acquired by exercising options. 1 filing: 1
- Apr 20, 2026, Protagonist Therapeutics, Inc: sold 1,750 shares for $185K, to cover taxes. 1 filing: 1
- Mar 26, 2026, Protagonist Therapeutics, Inc: sold 24,765 shares for $2.6M, no plan disclosed; 24,765 shares acquired by exercising options. 1 filing: 1
- Jan 27, 2026, Protagonist Therapeutics, Inc: sold 46,203 shares for $3.8M, no plan disclosed; 28,000 shares acquired by exercising options. 1 filing: 1
- Jan 20, 2026, Protagonist Therapeutics, Inc: sold 8,588 shares for $708K, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.